Cellular Origins and Fresenius Kabi have completed the first phase of a CGT manufacturing collaboration announced in October ...

Cellular manufacturing systems (CMS) represent a pivotal approach to modern industrial production, in which machines and workstations are organised into discrete cells dedicated to the manufacture of ...

Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...

Cellular Origins announces the completion of a USD 40 million (EUR 34.3 million) over-subscribed Series A round. The Series A financing was led by Johnson & Johnson, through its corporate venture ...

A study led by the School of Engineering of the Hong Kong University of Science and Technology (HKUST) has developed an innovative method that overcomes the limitations of traditional additive ...